The role of the D2 dopamine receptor (D2R) in A2A adenosine receptor (A2AR)-mediated behavioral and cellular responses as revealed by A2A and D2 receptor knockout mice

• Autores: Chen, Jiang Fan; Moratalla, Rosario; Impagnatiello, Francesco; Grandy, David K.; Cuellar, Beatriz; Rubinstein, Marcelo; Beilstein, Mark A.; Hackett, Elizabeth; Fink, J. Stephen; Low, Malcolm J.; Ongini, Ennio; Schwarzschild, Michael A.
• Año de publicación: 2001
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: dopamina; adenosina
• Institución: Consejo Nacional de Investigaciones Científicas y Técnicas

The A2AR is largely coexpressed with D2Rs and enkephalin mRNA in the striatum where it modulates dopaminergic activity. Activation of the A2AR antagonizes D2R-mediated behavioral and neurochemical effects in the basal ganglia through a mechanism that may involve direct A2AR-D2R interaction. However, whether the D2R is required for the A2AR to exert its neural function is an open question. In this study, we examined the role of D2Rs in A2AR-induced behavioral and cellular responses, by using genetic knockout (KO) models (mice deficient in A2ARs or D2Rs or both). Behavioral analysis shows that the A2AR agonist 2-4-(2-carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine reduced spontaneous as well as amphetamine-induced locomotion in both D2 KO and wild-type mice. Conversely, the nonselective adenosine antagonist caffeine and the A2AR antagonist 8-(3-chlorostyryl)caffeine produced motor stimulation in mice lacking the D2R, although the stimulation was significantly attentuated. At the cellular level, A2AR inactivation counteracted the increase in enkephalin expression in striatopallidal neurons caused by D2R deficiency. Consistent with the D2 KO phenotype, A2AR inactivation partially reversed both acute D2R antagonist (haloperidol)-induced catalepsy and chronic haloperidol-induced enkephalin mRNA expression. Together, these results demonstrate that A2ARs elicit behavioral and cellular responses despite either the genetic deficiency or pharmacological blockade of D2Rs. Thus, A2AR-mediated neural functions are partially independent of D2Rs. Moreover, endogenous adenosine acting at striatal A2ARs may be most accurately viewed as a facilitative modulator of striatal neuronal activity rather than simply as an inhibitory modulator of D2R neurotransmission.
Fil: Chen, Jiang Fan. Harvard Medical School; Estados Unidos. Massachusetts General Hospital; Estados Unidos
Fil: Moratalla, Rosario. Instituto Cajal; España
Fil: Impagnatiello, Francesco. Schering-Plough Research Institute; Italia
Fil: Grandy, David K.. University of Oregon; Estados Unidos
Fil: Cuellar, Beatriz. Instituto Cajal; España
Fil: Rubinstein, Marcelo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Beilstein, Mark A.. Harvard Medical School; Estados Unidos. Massachusetts General Hospital; Estados Unidos
Fil: Hackett, Elizabeth. Harvard Medical School; Estados Unidos. Massachusetts General Hospital; Estados Unidos
Fil: Fink, J. Stephen. Harvard Medical School; Estados Unidos. Massachusetts General Hospital; Estados Unidos. Boston University; Estados Unidos
Fil: Low, Malcolm J.. University of Oregon; Estados Unidos
Fil: Ongini, Ennio. Schering-Plough Research Institute; Italia
Fil: Schwarzschild, Michael A.. Harvard Medical School; Estados Unidos. Massachusetts General Hospital; Estados Unidos